1. Home
  2. DRD vs WVE Comparison

DRD vs WVE Comparison

Compare DRD & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DRDGOLD Limited

DRD

DRDGOLD Limited

HOLD

Current Price

$25.92

Market Cap

2.5B

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.33

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRD
WVE
Founded
1895
2012
Country
South Africa
Singapore
Employees
3410
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
DRD
WVE
Price
$25.92
$6.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
16
Target Price
$32.63
$29.81
AVG Volume (30 Days)
234.3K
4.2M
Earning Date
08-19-2026
04-28-2026
Dividend Yield
2.24%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
$39.23
N/A
Revenue Next Year
$30.12
$85.67
P/E Ratio
$15.32
N/A
Revenue Growth
N/A
149.43
52 Week Low
$13.08
$5.02
52 Week High
$39.37
$21.73

Technical Indicators

Market Signals
Indicator
DRD
WVE
Relative Strength Index (RSI) 38.87 34.87
Support Level $23.26 $5.02
Resistance Level $30.99 $7.65
Average True Range (ATR) 1.06 0.38
MACD -0.22 0.01
Stochastic Oscillator 5.78 19.12

Price Performance

Historical Comparison
DRD
WVE

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: